Literature DB >> 2764644

Inhibition of lipid peroxidation by idebenone in brain mitochondria in the presence of succinate.

M Suno1, A Nagaoka.   

Abstract

Lipid peroxidation in brain mitochondria was induced by NADH in the presence of ADP and FeCl3. A novel quinone compound, idebenone, inhibited this peroxidation and the inhibition was markedly enhanced by succinate, a substrate of mitochondrial respiration. The concentration of succinate required to exert the maximal effect was 1.5 mM. The concentration of idebenone giving 50% inhibition (IC50) was 0.5 and 84 microM in the presence and absence of succinate, respectively, indicating that succinate enhances the inhibition by 170-fold. Moreover, the inhibitory effect of idebenone in the presence of succinate was abolished by adding thenoyltrifluoroacetate (TTFA), an inhibitor of complex II in the mitochondrial respiratory chain. These results indicate that idebenone is changed through complex II to its reduced form, which protects mitochondria against lipid peroxidation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2764644     DOI: 10.1016/0167-4943(89)90010-1

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  15 in total

Review 1.  Friedreich ataxia-update on pathogenesis and possible therapies.

Authors:  Max Voncken; Panos Ioannou; Martin B Delatycki
Journal:  Neurogenetics       Date:  2003-12-19       Impact factor: 2.660

2.  A Strategy for Suppressing Redox Stress within Mitochondria.

Authors:  Pablo M Arce; Omar M Khdour; Ruth Goldschmidt; Jeffrey S Armstrong; Sidney M Hecht
Journal:  ACS Med Chem Lett       Date:  2011-05-31       Impact factor: 4.345

3.  Protective effects of Fe-Aox29, a novel antioxidant derived from a molecular combination of Idebenone and vitamin E, in immortalized fibroblasts and fibroblasts from patients with Friedreich Ataxia.

Authors:  Matthias L Jauslin; Silvia Vertuani; Elisa Durini; Lisa Buzzoni; Nunzia Ciliberti; Sara Verdecchia; Paola Palozza; Thomas Meier; Stefano Manfredini
Journal:  Mol Cell Biochem       Date:  2007-05-03       Impact factor: 3.396

4.  Idebenone Ameliorates Rotenone-Induced Parkinson's Disease in Rats Through Decreasing Lipid Peroxidation.

Authors:  Bahattin Avcı; Caner Günaydın; Tolga Güvenç; Canan Kulcu Yavuz; Nilufer Kuruca; S Sirri Bilge
Journal:  Neurochem Res       Date:  2020-11-28       Impact factor: 3.996

Review 5.  Idebenone and neuroprotection: antioxidant, pro-oxidant, or electron carrier?

Authors:  Sausan Jaber; Brian M Polster
Journal:  J Bioenerg Biomembr       Date:  2014-09-28       Impact factor: 2.945

6.  Idebenone protects against retinal damage and loss of vision in a mouse model of Leber's hereditary optic neuropathy.

Authors:  Fabrice D Heitz; Michael Erb; Corinne Anklin; Dimitri Robay; Vincent Pernet; Nuri Gueven
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

7.  Features of idebenone and related short-chain quinones that rescue ATP levels under conditions of impaired mitochondrial complex I.

Authors:  Michael Erb; Barbara Hoffmann-Enger; Holger Deppe; Michael Soeberdt; Roman H Haefeli; Christian Rummey; Achim Feurer; Nuri Gueven
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

8.  NQO1-dependent redox cycling of idebenone: effects on cellular redox potential and energy levels.

Authors:  Roman H Haefeli; Michael Erb; Anja C Gemperli; Dimitri Robay; Isabelle Courdier Fruh; Corinne Anklin; Robert Dallmann; Nuri Gueven
Journal:  PLoS One       Date:  2011-03-31       Impact factor: 3.240

9.  Mitochondrial biogenesis and neural differentiation of human iPSC is modulated by idebenone in a developmental stage-dependent manner.

Authors:  J Augustyniak; J Lenart; M Zychowicz; P P Stepien; L Buzanska
Journal:  Biogerontology       Date:  2017-06-22       Impact factor: 4.277

Review 10.  Mitochondrial dysfunction in obesity: potential benefit and mechanism of Co-enzyme Q10 supplementation in metabolic syndrome.

Authors:  Md Ashraful Alam; Md Mahbubur Rahman
Journal:  J Diabetes Metab Disord       Date:  2014-05-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.